[go: up one dir, main page]

DK603789D0 - Substituerede imidazolderivater og fremstilling og anvendelse deraf - Google Patents

Substituerede imidazolderivater og fremstilling og anvendelse deraf

Info

Publication number
DK603789D0
DK603789D0 DK603789A DK603789A DK603789D0 DK 603789 D0 DK603789 D0 DK 603789D0 DK 603789 A DK603789 A DK 603789A DK 603789 A DK603789 A DK 603789A DK 603789 D0 DK603789 D0 DK 603789D0
Authority
DK
Denmark
Prior art keywords
substituted
hal
preparation
alkyl
ch2ch3
Prior art date
Application number
DK603789A
Other languages
English (en)
Other versions
DK603789A (da
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Arja Leena Karjalainen
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of DK603789D0 publication Critical patent/DK603789D0/da
Publication of DK603789A publication Critical patent/DK603789A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK603789A 1988-12-09 1989-11-30 Substituerede imidazolderivater og fremstilling og anvendelse deraf DK603789A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8828831A GB2225782A (en) 1988-12-09 1988-12-09 Imidazole derivatives useful for treatment of diabetes

Publications (2)

Publication Number Publication Date
DK603789D0 true DK603789D0 (da) 1989-11-30
DK603789A DK603789A (da) 1990-06-10

Family

ID=10648267

Family Applications (1)

Application Number Title Priority Date Filing Date
DK603789A DK603789A (da) 1988-12-09 1989-11-30 Substituerede imidazolderivater og fremstilling og anvendelse deraf

Country Status (22)

Country Link
US (1) US5292887A (da)
EP (1) EP0372954B1 (da)
JP (1) JP2868813B2 (da)
KR (1) KR900009605A (da)
CN (1) CN1023219C (da)
AT (1) ATE102608T1 (da)
AU (1) AU619928B2 (da)
CA (1) CA2004799A1 (da)
DD (1) DD290880A5 (da)
DE (1) DE68913673T2 (da)
DK (1) DK603789A (da)
ES (1) ES2052937T3 (da)
FI (1) FI96026C (da)
GB (1) GB2225782A (da)
HU (1) HU205086B (da)
IE (1) IE61870B1 (da)
IL (1) IL92609A0 (da)
NO (1) NO177138C (da)
NZ (1) NZ231649A (da)
PT (1) PT92515B (da)
RU (2) RU1831479C (da)
ZA (1) ZA899366B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI862039A0 (fi) * 1986-05-15 1986-05-15 Farmos Oy Nytt foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat.
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9312669D0 (en) 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
FR2735776B1 (fr) * 1995-06-22 1997-07-18 Synthelabo Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
EP1147092A1 (en) * 1999-01-18 2001-10-24 Novo Nordisk A/S Substituted imidazoles, their preparation and use
FI20000073A0 (fi) * 2000-01-14 2000-01-14 Orion Yhtymae Oy Uusia imidatsolijohdannaisia
US6388090B2 (en) 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
PE20011321A1 (es) * 2000-05-08 2002-01-03 Orion Corp Indanilimizadoles policiclicos nuevos con actividad adrenergica alfa 2
FR2839719B1 (fr) * 2002-05-16 2004-08-06 Pf Medicament Nouveaux composes imidazoliques, leur procede de preparation et leur utilisation a titre de medicaments
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
FI81092C (fi) * 1986-05-15 1990-09-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.

Also Published As

Publication number Publication date
EP0372954B1 (en) 1994-03-09
CA2004799A1 (en) 1990-06-09
CN1023219C (zh) 1993-12-22
CN1043128A (zh) 1990-06-20
DE68913673D1 (de) 1994-04-14
HU205086B (en) 1992-03-30
EP0372954A1 (en) 1990-06-13
GB2225782A (en) 1990-06-13
ES2052937T3 (es) 1994-07-16
NO894563D0 (no) 1989-11-16
ZA899366B (en) 1991-03-27
DE68913673T2 (de) 1994-07-14
JPH02202874A (ja) 1990-08-10
HUT52065A (en) 1990-06-28
AU619928B2 (en) 1992-02-06
IE61870B1 (en) 1994-11-30
FI96026C (fi) 1996-04-25
NZ231649A (en) 1991-09-25
DD290880A5 (de) 1991-06-13
RU1831479C (ru) 1993-07-30
ATE102608T1 (de) 1994-03-15
DK603789A (da) 1990-06-10
PT92515B (pt) 1995-08-09
IE893926L (en) 1990-06-09
NO894563L (no) 1990-06-11
GB8828831D0 (en) 1989-01-18
FI895325A0 (fi) 1989-11-09
US5292887A (en) 1994-03-08
JP2868813B2 (ja) 1999-03-10
AU4599289A (en) 1990-08-16
NO177138C (no) 1995-07-26
FI96026B (fi) 1996-01-15
KR900009605A (ko) 1990-07-05
NO177138B (no) 1995-04-18
IL92609A0 (en) 1990-08-31
PT92515A (pt) 1990-06-29
RU1833375C (en) 1993-08-07

Similar Documents

Publication Publication Date Title
SE8601907L (sv) Antitrombogena och kardiotoniska imidazokinoliner
DK540485D0 (da) Substituerede imidazolderivater samt fremgangsmaade til fremstilling deraf og forbindelsernes anvendelse
ATE117295T1 (de) 4-oxochinolin-3-carbonsäure-derivate, ihre herstellung und ihre verwendung.
DK603789D0 (da) Substituerede imidazolderivater og fremstilling og anvendelse deraf
SE7703223L (sv) 2,3,4,4a-tetrahydro-1h-pyrazino(1,2-a)kinoxalin-5(6h)-on och derivat derav
FI872555A0 (fi) Antiallergiska och antiinflammatoriska aemnen.
DE3879258D1 (de) Praeparat gegen ulcus.
ES2058275T3 (es) Derivados biciclicos de sulfonamida y su preparacion, su uso y formulaciones que los contienen.
NO893039D0 (no) Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler.
ZA812541B (en) Benzothiazole derivatives and salts thereof,processes for their preparation,and their use as sweetening agents
ATE28192T1 (de) 4-alkylimidazol-derivate, ihre herstellung und verwendung.
DE3361437D1 (en) 4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxides, process for their preparation, their use and therapeutic agents containing them
DE3766884D1 (de) Trans-benzopyran-(4,3-b)-1,4-oxazinderivate.
DK382588D0 (da) Anti-psykotiske sammensaetninger indeholdende dioxopiperidin derivater
ES2040223T3 (es) Derivados de la tiadiazolilacetamida, procedimiento para su fabricacion y su utilizacion.
SE8900256L (sv) Ergolinderivat, deras framstaellning och deras anvaendning
ES8604174A1 (es) Procedimiento para la obtencion de isoxazoles
DE3772850D1 (de) Thiadiazinon-derivate.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment